Illustration: Gabriella Turrisi/Axios
Astromech is acquiring fellow Colossal Biosciences spinoff Form Bio for $230 million in stock, Colossal CEO Ben Lamm tells Axios Pro exclusively.
What's next: Astromech, valued at $3.8 billion as of August, plans to raise funding next year, Lamm says.